Switzerland
-
Lonza expands ADC manufacturing capacity at its Visp site in Switzerland
Lonza also plans to introduce 500-litre single-use manufacturing capacity across its existing mid-scale bioconjugation facilities from 2027.
-
Ferring Pharmaceuticals targets IVF innovation with US$1.38B Gameto acquisition in Switzerland
The deal also gives Ferring access to early-stage cell therapies and research models targeting other women’s health needs.
-
UNAIDS Board backs restructuring to maintain HIV services amid UN reforms
The Board took note of the final report of its Working Group and approved the overall strategic direction for the transition.
-
WHO welcomes UN Declaration on Pandemic Preparedness as countries face 2027 deadline for Pandemic Agreement
The declaration reaffirms commitments by UN Member States to strengthen pandemic preparedness, improve coordination and protect populations from infectious disease threats.
-
WHO launches five-year strategy to strengthen global epidemic intelligence by 2030
The new strategy will build on this work through five initiatives covering outbreak intelligence, pathogen surveillance, data science, collaborative surveillance and digital public health systems.
-
WHO reports 30% spike in global cholera deaths across 47 countries
Seven countries, which include Angola, Bangladesh, the Democratic Republic of the Congo, Nigeria, South Sudan, Sudan and Yemen, accounted for about 90% of reported cases and deaths.
-
WHO issues new family planning guidance in Switzerland to broaden global contraceptive options
In its new publication, WHO Guidelines on Expanding Contraceptive Options, WHO provides countries with evidence-based recommendations to broaden access to contraceptive methods and offer more flexibility in how people use them.
-
Sandoz expands biosimilar pipeline with mAbxience deal for haemophilia A treatment
The agreement covers licensing, development, manufacturing and commercialisation of the candidate, which is currently in the early stages of development.
-
ADI releases 2026 World Alzheimer Report ahead of major trial recruitment push
Researchers will need about 55,000 participants to support currently active studies.
-
WHO signs four-year accord with Commonwealth Secretariat to boost health resilience
It builds on an earlier MoU signed by the two organisations in 2022 and sets out areas for deeper collaboration on health system strengthening and emerging health challenges.